Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences Track

Radiomics Analysis of Longitudinal DaTscan Images for Improved Progression Tracking in Parkinson’s Disease

Peng Huang, Nikolay Shenkov, Sima Fotouhi, Esmaeil Davoodi-Bojd, Lijun Lu, Zoltan Mari, Hamid Soltanian-Zadeh, Vesna Sossi and Arman Rahmim
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 412;
Peng Huang
3Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikolay Shenkov
1Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sima Fotouhi
3Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esmaeil Davoodi-Bojd
3Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lijun Lu
4Southern Medical University Guangzhou China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zoltan Mari
3Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hamid Soltanian-Zadeh
2Henry Ford Health System Detroit MI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vesna Sossi
5UBC Vancouver BC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arman Rahmim
3Johns Hopkins University Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

412

Objectives: DaTscan is increasingly utilized for diagnostic purposes in suspected parkinsonian syndromes. We aim to enable additional clinical utility of this modality for prognostication of Parkinson’s disease (PD). We investigated whether radiomics analysis (e.g. quantization of heterogeneity in uptake) as applied to longitudinal DaTscan images could predict UPDRS III (motor) for PD subjects.

Methods: We selected n=69 PD subjects from the Parkinson’s Progressive Marker Initiative (PPMI) database, who had at least 2 SPECT scans at baseline (year 0) and year 2 acquired on similar scanners (Siemens, 2-headed ECAM or Symbia systems), who underwent a high-resolution 3 T MRI scan, and for whom UPDRS assessment was available in years 0 (baseline), 2, and 4. Since routine quantitative analysis in DaTscan imaging does not assess spatial heterogeneity in uptake, we applied a framework wherein textural features were extracted from the images. This method does not require registration to a common template, and works in the subject-native space. Image analysis includes registration of SPECT images onto corresponding MRI images, automatic region-of-interest (ROI) extraction on the MRI images, and the extraction of various radiomic features. The outcome to predict is Y=year 4 motor score (UPDRS III). Non-imaging predictors included baseline measures of disease duration since symptom detection (DD-sympt.) and disease diagnosis (DD-diag.), as well as motor score, and non-motor (e.g. MoCA) clinical measures in years 0 and 2. The image predictors included 92 radiomic features extracted from the caudate, putamen, and ventral striatum of DaTscan images at years 0 and 2 to quantify heterogeneity and texture in uptake. Spearman correlation between each predictor and Y was calculated. Random forest (RF) with 5000 trees was used to combine both non-imaging and imaging variables to predict Y. The RF prediction was further evaluated using leave-one-out cross-validation. The analysis was repeated without radiomic features.

Results: Although 49 predictors were correlated with Y (unadjusted p-value<0.05), only motor scores at years 0 and 2, plus the radiomic feature eccentricity from the more affected ventral striatum, were significant with Benjamini & Hochberg adjusted p-value<0.05. The absolute difference between observed and predicted Y was D=2.74+/-2.78 (median 1.91, range 0.06~16.27) from RF and 6.75+/-6.39 (median 4.81, range 0.14~35.28) from leave-one-out cross-validation of RF. When excluding radiomics features, the D was increased to 3.26+/-3.04 (median 2.32, range 0.10~18.2) from RF, and 8.23+/-7.17 (median 6.03, range 0.31~41.4) from leave-one-out cross-validation of RF. Not making use of any imaging information, we obtain a D of 3.69+/-3.23 (median 3.02, range 0.07 ~ 17.2) from RF and 7.93 +/- 7.01 (median 6.13, range 0.0183 ~ 40.18) from leave-one-out cross-validation.

Conclusion: Our results demonstrated the ability to capture valuable information using quantitative striatal DAT SPECT imaging, enabling improved prediction of outcome when making use of radiomic features. Radiomic analysis of DAT SPECT has significant potential towards development of effective biomarkers for PD outcome. Research Support: The project was supported by the Michael J. Fox Foundation, including use of data available from the PPMI—a public-private partnership—funded by The Michael J. Fox Foundation for Parkinson's Research and funding partners (listed at www.ppmi-info.org/fundingpartners). This work was also supported by the Natural Sciences and Engineering Research Council of Canada. Table 1. Absolute difference (=D) between observed year 4 UPDRS III (Y) and prediction from random forest (RF)

View this table:
  • View inline
  • View popup

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radiomics Analysis of Longitudinal DaTscan Images for Improved Progression Tracking in Parkinson’s Disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Radiomics Analysis of Longitudinal DaTscan Images for Improved Progression Tracking in Parkinson’s Disease
Peng Huang, Nikolay Shenkov, Sima Fotouhi, Esmaeil Davoodi-Bojd, Lijun Lu, Zoltan Mari, Hamid Soltanian-Zadeh, Vesna Sossi, Arman Rahmim
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 412;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radiomics Analysis of Longitudinal DaTscan Images for Improved Progression Tracking in Parkinson’s Disease
Peng Huang, Nikolay Shenkov, Sima Fotouhi, Esmaeil Davoodi-Bojd, Lijun Lu, Zoltan Mari, Hamid Soltanian-Zadeh, Vesna Sossi, Arman Rahmim
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 412;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences Track

  • Impact of cognitive reserve in frontotemporal dementia illustrated by FDG-PET.
  • Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with 18F-FEOBV
  • Kinetic evaluation of [18F]MOZAT PET imaging in humans.
Show more Neurosciences Track

New Approaches to Image Parkinson Syndrome

  • Utility of F-18-THK-5351 Tau-PET for Differential Diagnosis in Patients with Hypokinetic-rigid Syndromes
  • Management impact of imaging brain vesicular monoamine transporter type-2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS) with 18F-AV133 and PET
  • Comparing patterns of brain amyloid deposition in Parkinson’s disease to Alzheimer’s disease and cognitively normal controls using [18F] florbetapir PET imaging
Show more New Approaches to Image Parkinson Syndrome

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire